These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results. Cole LA; Khanlian SA; Muller CY J Reprod Med; 2008 Jul; 53(7):457-64. PubMed ID: 18720919 [TBL] [Abstract][Full Text] [Related]
44. Advances in the understanding of placental site trophoblastic tumor. Feltmate CM; Genest DR; Goldstein DP; Berkowitz RS J Reprod Med; 2002 May; 47(5):337-41. PubMed ID: 12063871 [TBL] [Abstract][Full Text] [Related]
45. MR appearance of placental site trophoblastic tumor: a report of three cases. Brandt KR; Coakley KJ AJR Am J Roentgenol; 1998 Feb; 170(2):485-7. PubMed ID: 9456970 [TBL] [Abstract][Full Text] [Related]
46. Metastatic placental site trophoblastic tumor. Report of a case with complete response to chemotherapy. Mangili G; Garavaglia E; De Marzi P; Zanetto F; Taccagni G J Reprod Med; 2001 Mar; 46(3):259-62. PubMed ID: 11304870 [TBL] [Abstract][Full Text] [Related]
47. [Clinical characteristics and management of gestational trophoblastic disease in women aged 50 years or more]. Feng FZ; Xiang Y; Wan XR; Yin SJ; Yang XY Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):605-8. PubMed ID: 16202316 [TBL] [Abstract][Full Text] [Related]
48. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor. Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457 [TBL] [Abstract][Full Text] [Related]
49. Postmenopausal bleeding resulting from placental site trophoblastic tumor of the uterus: a case report. Fallahian M; Jafari B J Reprod Med; 2004 May; 49(5):392-4. PubMed ID: 15214716 [TBL] [Abstract][Full Text] [Related]
50. Recurrent placental site trophoblastic tumor of the uterus: clinical, pathologic, ultrastructural, and DNA fingerprint study. Kodama S; Kase H; Aoki Y; Yahata T; Tanaka K; Motoyama T; Dewa K Gynecol Oncol; 1996 Jan; 60(1):89-93. PubMed ID: 8557234 [TBL] [Abstract][Full Text] [Related]
51. [Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour]. Xiang Y; Wan XR; Sun ZJ; Yang XY Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):79-82. PubMed ID: 15840283 [TBL] [Abstract][Full Text] [Related]
52. Impact of p53 immunostaining in predicting advanced or recurrent placental site trophoblastic tumors: a study of 12 cases. Nagai Y; Kamoi S; Matsuoka T; Hata A; Jobo T; Ogasawara T; Aoki Y; Ohira S; Okamoto T; Nakamoto T; Kanda K; Matsui H Gynecol Oncol; 2007 Sep; 106(3):446-52. PubMed ID: 17544490 [TBL] [Abstract][Full Text] [Related]
53. Diagnosis and treatment of placental site trophoblastic tumor. Huang F; Zheng W; Liang Q; Yin T Int J Clin Exp Pathol; 2013; 6(7):1448-51. PubMed ID: 23826431 [TBL] [Abstract][Full Text] [Related]
55. Extrauterine Placental Site Trophoblastic Tumor Involving the Vagina. Gupta M; Gnanasekaran KK; Manojkumar R; Thomas A; Sebastian A Int J Gynecol Pathol; 2017 May; 36(3):294-299. PubMed ID: 27513078 [TBL] [Abstract][Full Text] [Related]